Literature DB >> 21475961

The role of activin in mammary gland development and oncogenesis.

Karen A Dunphy1, Alan L Schneyer, Mary J Hagen, D Joseph Jerry.   

Abstract

TGFβ contributes to mammary gland development and has paradoxical roles in breast cancer because it has both tumor suppressor and tumor promoter activity. Another member of the TGFβ superfamily, activin, also has roles in the developing mammary gland, but these functions, and the role of activin in breast cancer, are not well characterized. TGFβ and activin share the same intracellular signaling pathways, but divergence in their signaling pathways are suggested. The purpose of this review is to compare the spatial and temporal expression of TGFβ and activin during mammary gland development, with consideration given to their functions during each developmental period. We also review the contributions of TGFβ and activin to breast cancer resistance and susceptibility. Finally, we consider the systemic contributions of activin in regulating obesity and diabetes; and the impact this regulation has on breast cancer. Elevated levels of activin in serum during pregnancy and its influence on pregnancy associated breast cancer are also considered. We conclude that evidence demonstrates that activin has tumor suppressing potential, without definitive indication of tumor promoting activity in the mammary gland, making it a good target for development of therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475961     DOI: 10.1007/s10911-011-9214-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  107 in total

1.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

Review 2.  Follistatin and its role as an activin-binding protein.

Authors:  H Sugino; K Sugino; O Hashimoto; H Shoji; T Nakamura
Journal:  J Med Invest       Date:  1997-08

3.  FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.

Authors:  L Bartholin; V Maguer-Satta; S Hayette; S Martel; M Gadoux; S Bertrand; L Corbo; C Lamadon; A M Morera; J P Magaud; R Rimokh
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

Review 4.  Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

Authors:  Kimberly S Peairs; Bethany B Barone; Claire F Snyder; Hsin-Chieh Yeh; Kelly B Stein; Rachel L Derr; Frederick L Brancati; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

5.  Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.

Authors:  E Bloise; G D Cassali; M C Ferreira; P Ciarmela; F Petraglia; F M Reis
Journal:  J Dairy Sci       Date:  2010-10       Impact factor: 4.034

6.  Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.

Authors:  Jelena Krneta; Jens Kroll; Frauke Alves; Claudia Prahst; Farahnaz Sananbenesi; Christian Dullin; Sarah Kimmina; David J Phillips; Hellmut G Augustin
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

7.  TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.

Authors:  Brian Bierie; Agnieszka E Gorska; Daniel G Stover; Harold L Moses
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

8.  Transforming growth factor beta signaling through Smad1 in human breast cancer cells.

Authors:  X Liu; J Yue; R S Frey; Q Zhu; K M Mulder
Journal:  Cancer Res       Date:  1998-10-15       Impact factor: 12.701

Review 9.  Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.

Authors:  He Li; Jun-Ping Liu
Journal:  Ann N Y Acad Sci       Date:  2007-10-12       Impact factor: 5.691

10.  Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland.

Authors:  G B Silberstein; P Strickland; S Coleman; C W Daniel
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  5 in total

1.  Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives.

Authors:  Moulay Aalaoui-Jamali; Krikor Bijian; Gerald Batist
Journal:  Am J Transl Res       Date:  2011-09-08       Impact factor: 4.060

2.  Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression.

Authors:  Fancai Zeng; Guoxiong Xu; Tiejun Zhou; Chengwan Yang; Xinyan Wang; Chun Peng; Hong Zhou
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

3.  Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.

Authors:  Karen A Dunphy; Jae-Hong Seo; Daniel J Kim; Amy L Roberts; Luwei Tao; James DiRenzo; Amanda L Balboni; Giovanna M Crisi; Mary J Hagen; Thiruppavai Chandrasekaran; Kelly J Gauger; Sallie Smith Schneider; D Joseph Jerry
Journal:  Cancer Cell Int       Date:  2013-07-25       Impact factor: 5.722

4.  Role of stromal activin A in human pancreatic cancer and metastasis in mice.

Authors:  Paul Grippo; Barbara Jung; Georgina Mancinelli; Carolina Torres; Nancy Krett; Jessica Bauer; Karla Castellanos; Ron McKinney; David Dawson; Grace Guzman; Rosa Hwang; Sam Grimaldo
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

5.  Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer.

Authors:  Mohsin Bashir; Surekha Damineni; Geetashree Mukherjee; Paturu Kondaiah
Journal:  NPJ Breast Cancer       Date:  2015-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.